Lunai Bioworks, Inc. (LNAI)
1.93
-0.01
(-0.52%)
USD |
NASDAQ |
Sep 25, 16:00
1.90
-0.03
(-1.55%)
After-Hours: 19:59
Lunai Bioworks EPS Diluted (Quarterly) : -0.823 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -0.823 |
| December 31, 2025 | -0.613 |
| September 30, 2025 | 1.001 |
| June 30, 2025 | -60.86 |
| March 31, 2025 | 0.092 |
| December 31, 2024 | -3.586 |
| September 30, 2024 | -0.2824 |
| June 30, 2024 | -0.1015 |
| March 31, 2024 | -0.4765 |
| December 31, 2023 | -0.0688 |
| September 30, 2023 | -0.1423 |
| June 30, 2023 | -0.3642 |
| March 31, 2023 | -0.0773 |
| December 31, 2022 | -0.0803 |
| September 30, 2022 | -0.1397 |
| June 30, 2022 | -1.702 |
| March 31, 2022 | -0.1178 |
| December 31, 2021 | -0.1258 |
| September 30, 2021 | -0.1994 |
| June 30, 2021 | -0.3325 |
| March 31, 2021 | -0.0862 |
| December 31, 2020 | -0.0629 |
| September 30, 2020 | -0.0514 |
| June 30, 2020 | -0.0881 |
| March 31, 2020 | -0.0327 |
| Date | Value |
|---|---|
| December 31, 2019 | -0.0372 |
| September 30, 2019 | -0.0883 |
| June 30, 2019 | 0.1543 |
| March 31, 2019 | -5.892 |
| December 31, 2018 | -35.62 |
| September 30, 2018 | -0.7744 |
| June 30, 2018 | -0.1352 |
| March 31, 2018 | -0.12 |
| December 31, 2017 | -0.078 |
| September 30, 2017 | -0.02 |
| June 30, 2017 | -0.0149 |
| March 31, 2017 | -0.03 |
| December 31, 2016 | -0.10 |
| September 30, 2016 | -0.08 |
| June 30, 2016 | -0.08 |
| March 31, 2016 | -0.02 |
| December 31, 2015 | -0.04 |
| September 30, 2015 | -0.04 |
| March 31, 2015 | -0.13 |
| December 31, 2014 | -0.14 |
| September 30, 2014 | -0.0513 |
| June 30, 2014 | -0.045 |
| June 30, 2013 | -0.0006 |
| March 31, 2013 | -0.0019 |
| December 31, 2012 | -0.002 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | -0.0146 |
| Amgen, Inc. | 4.366 |
| Anika Therapeutics, Inc. | 0.2412 |
| BioCryst Pharmaceuticals, Inc. | 0.2957 |
| Imunon, Inc. | -0.5412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.571M |
| Revenue (Quarterly) | 0.0209M |
| Total Expenses (Quarterly) | 2.592M |
| Enterprise Value | 6.886M |
| Gross Profit Margin (Quarterly) | 47.37% |
| Profit Margin (Quarterly) | -12.30K% |
| Earnings Yield | -3.18K% |
| Normalized Earnings Yield | -947.72 |